by Jordana Choucair | Nov 18, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved the first drug to prevent type 1 diabetes. Tzield, from ProventionBio and Sanofi, was approved to delay the onset of stage 3 type 1 diabetes in adults and children ages 8 and up who currently have stage 2 type 1...
by Jordana Choucair | Nov 18, 2022 | Opioid/Substance Use Disorders
A study published in JAMA Network Open found that individuals with substance use disorders (SUDs) had significant annual declines in SUD-related emergency department use over five years compared with patients who received “usual care.” The study notes that...
by Jordana Choucair | Nov 18, 2022 | Payers
Centene announced it will sell its Magellan Specialty Health to administrator Evolent Health (Evolent) as part of the insurer’s ongoing efforts to jettison its non-health plan businesses. Evolent will pay at least $400 million in cash and approximately $200 million in...
by Jordana Choucair | Nov 18, 2022 | Providers
The American Medical Association (AMA) adopted a new policy that aims to protect residents who are training at teaching hospitals bought by private equity firms. The policy is in response to concerns that firms are trimming operations to increase profits following...
by Jordana Choucair | Nov 18, 2022 | Providers
Intermountain Healthcare named Robert Allen as its new president and CEO effective December 1. Allen joined Intermountain in 2008 and has served as its chief operating officer since 2017. He will replace Interim President and CEO Lydia Jumonville, who has been leading...
by Jordana Choucair | Nov 17, 2022 | Access & Coverage
The Urban Institute released a new policy brief revealing that 62 percent of Medicaid recipients are unaware that states will redetermine their Medicaid eligibility when the COVID-19 public health emergency ends. Approximately one-third (30.6 percent) of respondents...
Recent Comments